A. Pedersen

777 total citations
22 papers, 641 citations indexed

About

A. Pedersen is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, A. Pedersen has authored 22 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in A. Pedersen's work include Protease and Inhibitor Mechanisms (6 papers), Peptidase Inhibition and Analysis (5 papers) and Blood donation and transfusion practices (4 papers). A. Pedersen is often cited by papers focused on Protease and Inhibitor Mechanisms (6 papers), Peptidase Inhibition and Analysis (5 papers) and Blood donation and transfusion practices (4 papers). A. Pedersen collaborates with scholars based in Denmark, United Kingdom and Sweden. A. Pedersen's co-authors include Nils Brünner, Hans Jørgen Nielsen, Claus M. Reimert, P. Stahl Skov, Ross W. Stephens, E. Dybkjær, L Edvardsen, Henrik Kehlet, Mads Holten-Andersen and Gillian Murphy and has published in prestigious journals such as The FASEB Journal, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

A. Pedersen

22 papers receiving 616 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Pedersen Denmark 9 282 202 170 141 93 22 641
H. Wang United States 8 92 0.3× 206 1.0× 132 0.8× 66 0.5× 184 2.0× 21 614
G. A. T. Hawson Australia 11 121 0.4× 136 0.7× 70 0.4× 182 1.3× 116 1.2× 24 664
Alex Chase United Kingdom 6 170 0.6× 62 0.3× 41 0.2× 54 0.4× 56 0.6× 10 489
Gabriela Cesarman Mexico 7 233 0.8× 70 0.3× 48 0.3× 407 2.9× 449 4.8× 10 851
Mario Koksch Germany 16 20 0.1× 57 0.3× 26 0.2× 221 1.6× 188 2.0× 22 678
Tiffany Tanaka United States 11 51 0.2× 118 0.6× 30 0.2× 311 2.2× 184 2.0× 30 572
Ricardo J. Ramirez United States 12 142 0.5× 226 1.1× 29 0.2× 16 0.1× 390 4.2× 24 756
Ankur R. Parikh United States 8 133 0.5× 134 0.7× 16 0.1× 583 4.1× 139 1.5× 15 861
Kyong Sik Lee South Korea 18 215 0.8× 253 1.3× 15 0.1× 27 0.2× 172 1.8× 45 702

Countries citing papers authored by A. Pedersen

Since Specialization
Citations

This map shows the geographic impact of A. Pedersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Pedersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Pedersen more than expected).

Fields of papers citing papers by A. Pedersen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Pedersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Pedersen. The network helps show where A. Pedersen may publish in the future.

Co-authorship network of co-authors of A. Pedersen

This figure shows the co-authorship network connecting the top 25 collaborators of A. Pedersen. A scholar is included among the top collaborators of A. Pedersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Pedersen. A. Pedersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pedersen, A., Mikkel Andreassen, Åase Krogh Rasmussen, & Jesper Krogh. (2023). Desmopressin Dose Requirements in Adults with Congenital and Acquired Central Diabetes Insipidus. Hormone and Metabolic Research. 56(3). 206–213. 3 indexed citations
2.
3.
Slack, Robert J., Nik Hirani, Michael Gibbons, et al.. (2020). Translational pharmacology of TD139, an inhaled small molecule galectin‐3 (Gal‐3) inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF). The FASEB Journal. 34(S1). 1–1. 1 indexed citations
4.
Aznar, Marianne, et al.. (2013). A Combination of Volumetric Arc Therapy and Tangential Fields in Challenging Breast Cancer Cases. International Journal of Radiation Oncology*Biology*Physics. 87(2). S753–S753. 1 indexed citations
5.
Aznar, Marianne, Stine Korreman, A. Pedersen, et al.. (2011). Evaluation of dose to cardiac structures during breast irradiation. British Journal of Radiology. 84(1004). 743–746. 68 indexed citations
6.
Korreman, Stine, A. Pedersen, Lasse Rye Aarup, et al.. (2006). 203 Reduction of cardiac and pulmonary complication probabilities after breathing adapted radiotherapy for breast cancer. Radiotherapy and Oncology. 78. S70–S70. 2 indexed citations
7.
Korreman, Stine, Lasse Rye Aarup, Mari Olsen, et al.. (2005). 144 Changes in respiratory pattern during curative radiotherapy for lung cancer. Radiotherapy and Oncology. 76. S74–S75. 5 indexed citations
8.
Pedersen, A., et al.. (2003). Immunoassays of urokinase (uPA) and its type-1 inhibitor (PAI-1) in detergent extracts of breast cancer tissue. European Journal of Cancer. 39(7). 899–908. 5 indexed citations
9.
Holten-Andersen, Mads, Gillian Murphy, Hans Jørgen Nielsen, et al.. (1999). Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer. British Journal of Cancer. 80(3-4). 495–503. 128 indexed citations
10.
Mynster, Tommie, E. Dybkjær, Claus M. Reimert, et al.. (1999). Prestorage leukofiltration of whole blood and SAGM blood prevents extracellular bioactive substance accumulation. Inflammation Research. 48(7). 363–368. 6 indexed citations
11.
12.
Stephens, Ross W., et al.. (1998). Plasminogen activator inhibitor type 1 (PAI-1), in cancer: A potential new target for antiinvasive and antimetastatic therapy. Drugs of the Future. 23(8). 873–873. 2 indexed citations
13.
Nielsen, Hans Jørgen, et al.. (1997). Leucocyte-derived bioactive substances in fresh frozen plasma. British Journal of Anaesthesia. 78(5). 548–552. 55 indexed citations
14.
Nielsen, Hans Jørgen, Flemming Skov, E. Dybkjær, et al.. (1997). Leucocyte and platelet‐derived bioactive substances in stored blood: effect of prestorage leucocyte filtration. European Journal Of Haematology. 58(4). 273–278. 24 indexed citations
15.
Nielsen, Hans Jørgen, Claus M. Reimert, A. Pedersen, et al.. (1996). Time‐dependent, spontaneous release of white cell‐ and platelet‐derived bioactive substances from stored human blood. Transfusion. 36(11-12). 960–965. 132 indexed citations
16.
Pappot, Helle, Henrik Gårdsvoll, John Rømer, et al.. (1995). Review. Biological Chemistry Hoppe-Seyler. 376(5). 259–280. 48 indexed citations
17.
Kornerup, H. J., E. B. Pedersen, A. Pedersen, Gitte Pedersen, & N. J. Christensen. (1980). Plasma catecholamines, renin and aldosterone during combined alpha- and beta- adrenoceptor blockade in patients with severe arterial hypertension.. PubMed. 56 Suppl 2. 49–52. 2 indexed citations
18.
Pedersen, Gitte, A. Pedersen, & Erling Bjerregaard Pedersen. (1979). Effect of propranolol on total exchangeable body potassium and total exchangeable body sodium in essential hypertension. Scandinavian Journal of Clinical and Laboratory Investigation. 39(2). 167–170. 15 indexed citations
19.
Kornerup, H. J., E. B. Pedersen, Niels Juel Christensen, A. Pedersen, & Gitte Pedersen. (1979). Effect of oral labetalol on plasma catecholamines, renin and aldosterone in patients with severe arterial hypertension. European Journal of Clinical Pharmacology. 16(5). 305–310. 7 indexed citations
20.
Kornerup, H. J., E. B. Pedersen, Niels Juel Christensen, A. Pedersen, & Gitte Pedersen. (1979). LABETALOL IN THE TREATMENT OF SEVERE ESSENTIAL HYPERTENSION: RELATIONSHIP BETWEEN ARTERIAL BLOOD PRESSURE, PLASMA CATECHOLAMINES, PLASMA RENIN ACTIVITY, PLASMA ALDOSTERONE AND BODY WEIGHT.. Acta Medica Scandinavica. 205(S625). 59–64. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. Wang Breakdown of academic impact, for papers by G. A. T. Hawson Breakdown of academic impact, for papers by Alex Chase Breakdown of academic impact, for papers by Gabriela Cesarman Breakdown of academic impact, for papers by Mario Koksch Breakdown of academic impact, for papers by Tiffany Tanaka Breakdown of academic impact, for papers by Ricardo J. Ramirez Breakdown of academic impact, for papers by Ankur R. Parikh Breakdown of academic impact, for papers by Kyong Sik Lee
Rankless by CCL
2026